【演讲专家简介】ANIMAL HEALTH INVESTMENT Europe

Mr. Aaron Schachtis currently the Vice President of Global Research and Development / RegulatoryAffairs at Elanco Animal Health.

星期三 10 1月 2018 (之前 5 月 10 天)

Pig333用户,注册可享受10%的优惠!

Pig333wechat
Pig333wechat

Pig333wechat
Pig333wechat

Mr. Aaron Schachtis currently the Vice President of Global Research and Development / RegulatoryAffairs at Elanco Animal Health. Prior to this, Mr. Aaron Schacht held a roleof Global Brand Development Leader – Pain in Lilly Biomedicines. He was the globalleader for product development and commercialization activities for LY2951742 –Lilly’s novel CGRP neutralizing antibody – a new potential treatment forprevention of Migraine and Cluster Headache. In 2012, Schacht joined LillyBiomedicines as Senior Advisor – Strategy & Business Development for LillyBioMedicines.

His responsibilities included oversight of Therapeutic Strategydevelopment, R&D Portfolio Management, and Business Development for LillyBioMedicines – Lilly’s largest business unit. Past roles included serving asExecutive Director, Global External R&D, at Eli Lilly and Company, where hewas responsible for implementation of strategies which aim to leverage novelapproaches to external partnerships to augment Lilly’s access to pharmaceuticalinnovation as well as Executive Director of LRL (Lilly Research Labs) Strategy,Portfolio Management and Project Management where he was responsible forstrategic planning, R&D portfolio and project management. Prior to theseroles, he was Director, Innovation Center in the eLilly organization where

hefocused on the exploration, incubation and implementation of new businessmodels and capabilities relevant to the strategic evolution of thepharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schachtwas co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MDcardiovascular drug discovery start-up. Mr. Schacht began his career at Lillyin 1990 as a medicinal chemist, and spent 5 years in the laboratory working todiscover pharmaceuticals to treat cardiovascular disorders. Schacht studiedOrganic chemistry at the University of Illinois, receiving his Bachelors ofScience degree in 1990.

行业报道

文章评论

在这里,您虽然无法就文章内容向作者咨询,但可以同pig333的其他用户进行探讨。

只有333用户才可以访问。如果想发表评论请登录。

非注册用户 333?注册可以查看猪价、检索信息...
快速并且免费
您是否已注册 333?登录如果您忘记了密码,我们可以发送给您 点击这里

tags